GLP ‐1 RA Therapy After Bariatric Surgery: Phenotype, Strategy and Success

Key Points

• This research aims to evaluate the effectiveness of GLP-1 receptor agonist (RA) therapy after bariatric surgery.
• Conducted a randomized trial with patients who underwent bariatric surgery.
• Assessed multiple phenotypes and strategies for therapy administration.
• Evaluated success metrics related to weight loss and metabolic improvements.
• Patients receiving GLP-1 RA therapy showed a significant increase in weight loss compared to control.
• Improved metabolic markers were observed, correlating with therapy adherence.
• Success rates indicated higher satisfaction and better long-term health outcomes.